Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.

Pulido MA, DerHartunian MK, Qin Z, Chung EM, Kang DS, Woodham AW, Tsou JA, Klooster R, Akbari O, Wang L, Kast WM, Liu SV, Verschuuren JJGM, Aswad DW, Laird-Offringa IA.

J Neuroimmunol. 2016 Oct 15;299:70-78. doi: 10.1016/j.jneuroim.2016.09.002. Epub 2016 Sep 3.

2.

Lung eQTLs to help reveal the molecular underpinnings of asthma.

Hao K, Bossé Y, Nickle DC, Paré PD, Postma DS, Laviolette M, Sandford A, Hackett TL, Daley D, Hogg JC, Elliott WM, Couture C, Lamontagne M, Brandsma CA, van den Berge M, Koppelman G, Reicin AS, Nicholson DW, Malkov V, Derry JM, Suver C, Tsou JA, Kulkarni A, Zhang C, Vessey R, Opiteck GJ, Curtis SP, Timens W, Sin DD.

PLoS Genet. 2012;8(11):e1003029. doi: 10.1371/journal.pgen.1003029. Epub 2012 Nov 29. Erratum in: PLoS Genet. 2012 Dec;8(12). doi: 10.1371/annotation/80d53ac6-4f5d-4c34-b92b-3fec00d514ac.

3.

UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study.

Wang YH, Trucksis M, McElwee JJ, Wong PH, Maciolek C, Thompson CD, Prueksaritanont T, Garrett GC, Declercq R, Vets E, Willson KJ, Smith RC, Klappenbach JA, Opiteck GJ, Tsou JA, Gibson C, Laethem T, Panorchan P, Iwamoto M, Shaw PM, Wagner JA, Harrelson JC.

Clin Pharmacol Ther. 2012 Jul;92(1):96-102. doi: 10.1038/clpt.2012.20. Epub 2012 Jun 6.

4.

Molecular signature of smoking in human lung tissues.

Bossé Y, Postma DS, Sin DD, Lamontagne M, Couture C, Gaudreault N, Joubert P, Wong V, Elliott M, van den Berge M, Brandsma CA, Tribouley C, Malkov V, Tsou JA, Opiteck GJ, Hogg JC, Sandford AJ, Timens W, Paré PD, Laviolette M.

Cancer Res. 2012 Aug 1;72(15):3753-63. Epub 2012 Jun 1.

5.

N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone.

Bhasin S, He EJ, Kawakubo M, Schroeder ET, Yarasheski K, Opiteck GJ, Reicin A, Chen F, Lam R, Tsou JA, Castaneda-Sceppa C, Binder EF, Azen SP, Sattler FR.

J Clin Endocrinol Metab. 2009 Nov;94(11):4224-33. doi: 10.1210/jc.2009-1434. Epub 2009 Oct 16.

6.

Low level anti-Hu reactivity: A risk marker for small cell lung cancer?

Tsou JA, Kazarian M, Patel A, Galler JS, Laird-Offringa IA, Carpenter CL, London SJ.

Cancer Detect Prev. 2009;32(4):292-9. doi: 10.1016/j.cdp.2008.06.006. Epub 2008 Dec 12.

7.

Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.

Tsou JA, Galler JS, Siegmund KD, Laird PW, Turla S, Cozen W, Hagen JA, Koss MN, Laird-Offringa IA.

Mol Cancer. 2007 Oct 29;6:70.

8.

DNA methylation profile of 28 potential marker loci in malignant mesothelioma.

Tsou JA, Galler JS, Wali A, Ye W, Siegmund KD, Groshen S, Laird PW, Turla S, Koss MN, Pass HI, Laird-Offringa IA.

Lung Cancer. 2007 Nov;58(2):220-30. Epub 2007 Jul 30.

9.

Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.

Tsou JA, Shen LY, Siegmund KD, Long TI, Laird PW, Seneviratne CK, Koss MN, Pass HI, Hagen JA, Laird-Offringa IA.

Lung Cancer. 2005 Feb;47(2):193-204.

PMID:
15639718
11.

DNA methylation analysis: a powerful new tool for lung cancer diagnosis.

Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA.

Oncogene. 2002 Aug 12;21(35):5450-61. Review.

12.

Hierarchical clustering of lung cancer cell lines using DNA methylation markers.

Virmani AK, Tsou JA, Siegmund KD, Shen LY, Long TI, Laird PW, Gazdar AF, Laird-Offringa IA.

Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):291-7.

Supplemental Content

Support Center